Newsfeeds Archive - Page 2 of 4

1 minute read

Traders Circulate Tweet Suggesting ‘Rigel Pharmas Rezlidhia Has Been Added To The National Comprehensive Cancer Networks Acute Myeloid Leukemia Guidelines As A Targeted Therapy Regimen’

January 13, 1:38 PM

https://twitter.com/TradeHawk/status/1613953239720005633?s=20&t=kAUpV8owISYDOHDZeBBijw https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf

RIGL

2 minute read

Rigel Announces Availability Of REZLIDHIA In The U.S. For The Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia With A Susceptible IDH1 Mutation

By Benzinga Newsdesk

December 22, 9:08 AM

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), today announced that REZLIDHIA™ (olutasidenib) capsules are available in the U.S. by prescription for the treatment of adult patients with relapsed or refractory (R/R)

RIGL

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

December 16, 1:31 PM

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 164.2% to $0.7 during Friday’s regular session. As of 12:30 EST, this…

ALLR

1 minute read

Citigroup Upgrades Rigel Pharmaceuticals to Buy

By Benzinga Newsdesk

December 2, 3:35 PM

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

RIGL

3 minute read

Dow Drops 100 Points; Asana Shares Plummet

By Lisa Levin

December 2, 3:30 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday.

ASAN

3 minute read

Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

December 2, 2:27 PM

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.

ASAN

3 minute read

Gold Down 1%; Samsara Shares Spike Higher

By Lisa Levin

December 2, 1:06 PM

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.

ASAN

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

December 2, 9:10 AM

Gainers Anavex Life Sciences (NASDAQ:AVXL) stock moved upwards by 60.1% to $14.2 during Friday’s pre-market session. The company’s…

AVXL

3 minute read

Rigel Announces U.S. FDA Approval Of REZLIDHIA (olutasidenib) For Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia With a Susceptible IDH1 Mutation

By Michael Horton

December 1, 6:05 PM

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that the U.S. Food and Drug Administration (FDA) has approved REZLIDHIA™ (olutasidenib) capsules for the treatment of adult patients with relapsed or

RIGL

1 minute read

Rigel Pharmaceuticals Q3 EPS $(0.11) Beats $(0.13) Estimate, Sales $22.41M Miss $22.61M Estimate

By Benzinga Newsdesk

November 3, 4:13 PM

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 8.33 percent increase over losses of $(0.12) per share

RIGL